Creation of a Psychedelic Science Interest Group at Yale University: A Case Study
Despite the ‘renaissance’ of psychedelic science in recent years, there is a paucity of structured educational initiatives at academic centers that illuminate this important and rapidly growing area of science. In mid-2015, a small group of psychiatry trainees and faculty members in psychology, nursing and psychiatry initiated plans to create an interdisciplinary forum at Yale University in which clinicians and scholars could discuss psychedelic science and applied therapeutics in an academically rigorous manner. Key topics of interest were identified and leading scholars in this field were invited as guest lecturers and discussion leaders. The Yale Psychedelic Science Group was subsequently approved and funded by the Yale Department of Psychiatry and has been hosting seminars since January 2016. Since its inception, the group has garnered significant attention from students and faculty from a variety of institutions and academic backgrounds, as well as from patients and journalists.
Jordan is a second year resident physician in psychiatry at the Yale School of Medicine. He was born and raised in Winnipeg, Canada, and has completed his bachelors degree in bioanthropology and a master’s degree in medical anthropology. While a medical student at Yale University, he pursued global health research and clinical opportunities in India, Nepal, Ecuador, Peru, and South Africa. His current interests include mental health system development in resource-poor settings, meditation and mindfulness-based psychotherapy, and the therapeutic application of psychedelic substances.